nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.021	0.0267	CbGpPWpGaD
Tolterodine—CHRM5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0201	0.0255	CbGpPWpGaD
Tolterodine—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0179	0.0227	CbGpPWpGaD
Tolterodine—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0174	0.0221	CbGpPWpGaD
Tolterodine—CHRM5—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0171	0.0218	CbGpPWpGaD
Tolterodine—CHRM5—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0166	0.0211	CbGpPWpGaD
Tolterodine—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0162	0.0206	CbGpPWpGaD
Tolterodine—Chlorphenamine—SLC6A3—Gilles de la Tourette syndrome	0.0161	0.43	CrCbGaD
Tolterodine—CHRM5—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0155	0.0197	CbGpPWpGaD
Tolterodine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.0153	0.0871	CbGeAlD
Tolterodine—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.015	0.0191	CbGpPWpGaD
Tolterodine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.0148	0.0838	CbGeAlD
Tolterodine—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0146	0.0186	CbGpPWpGaD
Tolterodine—CHRM5—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0144	0.0183	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0141	0.018	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0141	0.0179	CbGpPWpGaD
Tolterodine—CHRM5—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.014	0.0178	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.014	0.0178	CbGpPWpGaD
Tolterodine—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0136	0.0173	CbGpPWpGaD
Tolterodine—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.0136	0.362	CrCbGaD
Tolterodine—CHRM5—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.013	0.0166	CbGpPWpGaD
Tolterodine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0121	0.0153	CbGpPWpGaD
Tolterodine—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.012	0.0153	CbGpPWpGaD
Tolterodine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.012	0.068	CbGeAlD
Tolterodine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0119	0.0151	CbGpPWpGaD
Tolterodine—CHRM4—brain—Gilles de la Tourette syndrome	0.0117	0.0665	CbGeAlD
Tolterodine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0117	0.0149	CbGpPWpGaD
Tolterodine—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0117	0.0148	CbGpPWpGaD
Tolterodine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0116	0.0147	CbGpPWpGaD
Tolterodine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.0115	0.0655	CbGeAlD
Tolterodine—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0113	0.0144	CbGpPWpGaD
Tolterodine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0109	0.0139	CbGpPWpGaD
Tolterodine—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0109	0.0138	CbGpPWpGaD
Tolterodine—CHRM5—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0108	0.0138	CbGpPWpGaD
Tolterodine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0108	0.0137	CbGpPWpGaD
Tolterodine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0101	0.0129	CbGpPWpGaD
Tolterodine—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0101	0.0129	CbGpPWpGaD
Tolterodine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.01	0.0127	CbGpPWpGaD
Tolterodine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00984	0.0125	CbGpPWpGaD
Tolterodine—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00981	0.0125	CbGpPWpGaD
Tolterodine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00971	0.0124	CbGpPWpGaD
Tolterodine—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00952	0.0121	CbGpPWpGaD
Tolterodine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00917	0.0117	CbGpPWpGaD
Tolterodine—CHRM5—brain—Gilles de la Tourette syndrome	0.00917	0.052	CbGeAlD
Tolterodine—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00914	0.0116	CbGpPWpGaD
Tolterodine—CHRM5—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00912	0.0116	CbGpPWpGaD
Tolterodine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00905	0.0115	CbGpPWpGaD
Tolterodine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00823	0.0467	CbGeAlD
Tolterodine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00792	0.045	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.00779	0.208	CrCbGaD
Tolterodine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00764	0.00971	CbGpPWpGaD
Tolterodine—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00761	0.00968	CbGpPWpGaD
Tolterodine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00754	0.00959	CbGpPWpGaD
Tolterodine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00749	0.0425	CbGeAlD
Tolterodine—KCNH2—midbrain—Gilles de la Tourette syndrome	0.00723	0.041	CbGeAlD
Tolterodine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00721	0.0409	CbGeAlD
Tolterodine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00671	0.038	CbGeAlD
Tolterodine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00646	0.0366	CbGeAlD
Tolterodine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00642	0.00817	CbGpPWpGaD
Tolterodine—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0064	0.00814	CbGpPWpGaD
Tolterodine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00634	0.00806	CbGpPWpGaD
Tolterodine—CHRM2—brain—Gilles de la Tourette syndrome	0.00629	0.0357	CbGeAlD
Tolterodine—KCNH2—nervous system—Gilles de la Tourette syndrome	0.00595	0.0337	CbGeAlD
Tolterodine—CHRM1—brain—Gilles de la Tourette syndrome	0.00573	0.0325	CbGeAlD
Tolterodine—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.00572	0.0325	CbGeAlD
Tolterodine—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00534	0.00679	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00529	0.00672	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00518	0.00659	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00513	0.00653	CbGpPWpGaD
Tolterodine—CHRM3—brain—Gilles de la Tourette syndrome	0.00513	0.0291	CbGeAlD
Tolterodine—KCNH2—brain—Gilles de la Tourette syndrome	0.00454	0.0258	CbGeAlD
Tolterodine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00409	0.0052	CbGpPWpGaD
Tolterodine—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00373	0.00475	CbGpPWpGaD
Tolterodine—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00372	0.00473	CbGpPWpGaD
Tolterodine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00368	0.0209	CbGeAlD
Tolterodine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00363	0.0206	CbGeAlD
Tolterodine—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00361	0.00459	CbGpPWpGaD
Tolterodine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00355	0.0201	CbGeAlD
Tolterodine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00349	0.0198	CbGeAlD
Tolterodine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00345	0.00439	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00338	0.0043	CbGpPWpGaD
Tolterodine—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00336	0.00428	CbGpPWpGaD
Tolterodine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00335	0.00426	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00335	0.00426	CbGpPWpGaD
Tolterodine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0033	0.0042	CbGpPWpGaD
Tolterodine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00321	0.00408	CbGpPWpGaD
Tolterodine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00312	0.00397	CbGpPWpGaD
Tolterodine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00299	0.0038	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00296	0.00376	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00287	0.00365	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00284	0.00361	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00283	0.0036	CbGpPWpGaD
Tolterodine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00277	0.0157	CbGeAlD
Tolterodine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00276	0.00351	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00275	0.0035	CbGpPWpGaD
Tolterodine—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00271	0.00344	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00267	0.0034	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00257	0.00327	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00256	0.00326	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00248	0.00315	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00242	0.00308	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0024	0.00306	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00233	0.00296	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00232	0.00295	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0023	0.00292	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00226	0.00287	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00225	0.00286	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00225	0.00286	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00224	0.00285	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00223	0.00284	CbGpPWpGaD
Tolterodine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00219	0.00278	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00219	0.00278	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00218	0.00277	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00216	0.00274	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0021	0.00268	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0021	0.00267	CbGpPWpGaD
Tolterodine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00209	0.00266	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00209	0.00266	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00208	0.00264	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00204	0.00259	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00199	0.00254	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00199	0.00253	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00197	0.0025	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00195	0.00248	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00194	0.00246	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00193	0.00245	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00191	0.00243	CbGpPWpGaD
Tolterodine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00191	0.00243	CbGpPWpGaD
Tolterodine—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0019	0.00242	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00238	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0018	0.00229	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0018	0.00229	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00179	0.00228	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00178	0.00226	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00171	0.00217	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0017	0.00216	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00152	0.00193	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00151	0.00192	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0015	0.00191	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00187	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00147	0.00187	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00187	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00147	0.00187	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00145	0.00185	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00145	0.00185	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00145	0.00185	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00181	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00137	0.00175	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00137	0.00174	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00137	0.00174	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00136	0.00172	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00127	0.00162	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00126	0.00161	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00126	0.0016	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00125	0.00159	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00124	0.00157	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00122	0.00155	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00118	0.0015	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00116	0.00147	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00115	0.00146	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00112	0.00143	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00111	0.00141	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0011	0.0014	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00107	0.00137	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00104	0.00133	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.001	0.00127	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000962	0.00122	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000959	0.00122	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000949	0.00121	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.000943	0.0012	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000868	0.0011	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.00086	0.00109	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000858	0.00109	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000855	0.00109	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000847	0.00108	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000833	0.00106	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00083	0.00106	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000822	0.00105	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000806	0.00103	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000779	0.000991	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000777	0.000988	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000776	0.000987	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000773	0.000984	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000772	0.000982	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000769	0.000978	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000766	0.000974	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000756	0.000962	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000754	0.000959	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000747	0.00095	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000732	0.000931	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000705	0.000896	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000702	0.000893	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000701	0.000891	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000696	0.000885	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000683	0.000868	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000663	0.000843	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000654	0.000831	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000635	0.000807	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000617	0.000785	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000591	0.000752	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000567	0.000721	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000543	0.000691	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000542	0.000689	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000536	0.000682	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000494	0.000628	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000492	0.000626	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000487	0.00062	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00046	0.000585	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000459	0.000584	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000454	0.000578	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000447	0.000568	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000445	0.000566	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000441	0.000561	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000432	0.00055	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000416	0.000529	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000415	0.000528	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000414	0.000527	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000411	0.000523	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000292	0.000371	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000291	0.00037	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000288	0.000366	CbGpPWpGaD
